Late cerebral graft versus host reaction in a bone marrow transplanted girl with Hurler (MPS I) disease

M Kyllerman1, K Himmelmann, A Fasth

  • 1Department of Paediatric Neurology, The Queen Silvia Children's Hospital, Gothenburg, Sweden.

Neuropediatrics
|March 19, 2009
PubMed

Insights

A girl with Hurler disease (MPS IH) experienced graft-versus-host disease (GVHD) after stem cell transplant. Treatment with immunosuppressants reversed GVHD and normalized cerebrospinal fluid findings, indicating myelin stripping.

Area of Science:

  • Neurology
  • Immunology
  • Genetics

Background:

  • Hurler disease (Mucopolysaccharidosis type I - MPS IH) is a rare genetic disorder.
  • Allogeneic stem cell transplantation is a potential treatment for MPS IH.
  • Complications such as cerebral hemorrhage and graft-versus-host disease (GVHD) can occur post-transplantation.

Observation:

  • A patient with MPS IH developed ventriculitis and suspected GVHD one year after stem cell transplantation.
  • Cerebrospinal fluid (CSF) analysis revealed increased albumin and pleocytosis.
  • Electron microscopy and biochemical analysis of CSF sediment identified myelin debris.

Findings:

  • Subacute GVHD in the central nervous system led to stripping and desquamation of central myelin into the CSF.
  • Treatment with prednisolone and cyclosporine effectively reversed GVHD and normalized CSF parameters.
  • Myelin debris in CSF, confirmed by electron microscopy and biochemical analysis, indicated CNS involvement.

Implications:

  • This case highlights a rare manifestation of CNS GVHD in MPS IH patients post-transplantation.
  • Early diagnosis and aggressive immunosuppressive therapy are crucial for managing CNS GVHD.
  • Understanding myelin breakdown products in CSF can aid in diagnosing neurological complications after stem cell transplantation.